CURISCARE APS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  26.0% 16.4% 22.2% 17.9% 22.0%  
Credit score (0-100)  3 11 3 8 2  
Credit rating  B BB B B B  
Credit limit (kDKK)  -0.0 -0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  28.2 -0.2 117 88.2 -18.3  
EBITDA  -91.9 -11.7 15.1 7.1 -35.0  
EBIT  -91.9 -11.7 15.1 7.1 -35.0  
Pre-tax profit (PTP)  -93.4 -11.8 14.7 7.0 -34.9  
Net earnings  -93.4 -11.8 14.7 7.0 -34.9  
Pre-tax profit without non-rec. items  -92.4 -11.8 14.7 7.0 -34.9  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -28.8 -40.5 -25.8 -18.8 -53.8  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1.4 5.1 12.3 7.9 7.6  

Net Debt  -1.4 -5.1 -12.3 -0.0 -5.5  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  28.2 -0.2 117 88.2 -18.3  
Gross profit growth  -84.6% 0.0% 0.0% -24.4% 0.0%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1 5 12 8 8  
Balance sheet change%  -98.6% 262.0% 142.5% -35.9% -3.8%  
Added value  -91.9 -11.7 15.1 7.1 -35.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 2.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -325.4% 5,488.3% 13.0% 8.0% 191.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -143.6% -30.8% 36.1% 21.8% -79.4%  
ROI %  -284.7% 0.0% 0.0% 0.0% 0.0%  
ROE %  -283.0% -363.3% 169.4% 69.4% -451.9%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -95.4% -88.9% -67.7% -70.5% -87.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1.5% 43.4% -81.4% -0.5% 15.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.1 0.3 0.3 0.1  
Current Ratio  0.0 0.1 0.3 0.3 0.1  
Cash and cash equivalent  1.4 5.1 12.3 0.0 5.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -28.8 -40.5 -25.8 -18.8 -53.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -35  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -35  
EBIT / employee  0 0 0 0 -35  
Net earnings / employee  0 0 0 0 -35